Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer.

[1]  M. Hauptmann,et al.  Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. , 2010, Archives of internal medicine.

[2]  V. Palmieri,et al.  Novel wall motion score-based method for estimating global left ventricular ejection fraction: validation by real-time 3D echocardiography and global longitudinal strain. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[3]  M. P. van den Berg,et al.  Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer , 2009, British Journal of Cancer.

[4]  E. D. de Vries,et al.  Cardiovascular toxicity caused by cancer treatment: strategies for early detection. , 2009, The Lancet. Oncology.

[5]  E. Noordijk,et al.  Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers. , 2008, International journal of radiation oncology, biology, physics.

[6]  D. Demsar,et al.  Cardiac damage after treatment of childhood cancer: A long-term follow-up , 2008, BMC Cancer.

[7]  James B. Seward,et al.  Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. , 2008, Journal of the American College of Cardiology.

[8]  A. Mavinkurve-Groothuis,et al.  THE ROLE OF BIOMARKERS IN THE EARLY DETECTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN CHILDREN: A Review of the Literature , 2008, Pediatric hematology and oncology.

[9]  P. Schwartz,et al.  Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. , 2007, Journal of the American College of Cardiology.

[10]  M. Louwman,et al.  Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[12]  T. Merchant,et al.  Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  W. Kamps,et al.  Changes in body composition after childhood cancer treatment: impact on future health status--a review. , 2007, Critical reviews in oncology/hematology.

[14]  M. Whooley,et al.  Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease. , 2007, The American journal of cardiology.

[15]  A. Mertens.  Cause of mortality in 5‐year survivors of childhood cancer , 2007, Pediatric blood & cancer.

[16]  A. Hart,et al.  Late cardiotoxicity after treatment for Hodgkin lymphoma. , 2007, Blood.

[17]  H. Caron,et al.  Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. , 2006, European journal of cancer.

[18]  Kevin C Oeffinger,et al.  Chronic health conditions in adult survivors of childhood cancer. , 2006, The New England journal of medicine.

[19]  J. Vonk,et al.  Long-term cardiac follow-up in survivors of a malignant bone tumour. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  J. Elaerts,et al.  Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[21]  S. Hancock,et al.  Diastolic dysfunction after mediastinal irradiation. , 2005, American heart journal.

[22]  P. Thompson,et al.  Prevention of coronary artery disease in cancer patients , 2005, Pediatric blood & cancer.

[23]  A. Smit,et al.  Left ventricular and cardiac autonomic function in survivors of testicular cancer , 2005, European journal of clinical investigation.

[24]  T. Björk-Eriksson,et al.  Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study , 2005, Acta oncologica.

[25]  G. Levitt,et al.  Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function , 2004, Heart.

[26]  S. Lipsitz,et al.  Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  P. Merlet,et al.  Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy , 2004, British Journal of Cancer.

[28]  Jeroen J. Bax,et al.  Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity. , 2003, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[29]  D. Faxon,et al.  ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca , 2003, Journal of the American College of Cardiology.

[30]  P. Riikonen,et al.  Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  H. Hense,et al.  Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. , 2003, European heart journal.

[32]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[33]  R. Senior,et al.  A prospective comparison of echocardiographic wall motion score index and radionuclide ejection fraction in predicting outcome following acute myocardial infarction , 2001, Heart.

[34]  E Glattre,et al.  Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  H. Crijns,et al.  Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables , 1999, Heart.

[36]  S. Lipsitz,et al.  Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  M. Dolgin,et al.  Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels , 1994 .

[38]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[39]  S. Colan,et al.  Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.

[40]  H. Robbe,et al.  Assessment of baroreceptor reflex sensitivity by means of spectral analysis. , 1987, Hypertension.

[41]  S. Ware,et al.  Diseases of the Myocardium , 2011 .

[42]  R. Maccormick.  Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty? , 2006, Medical hypotheses.

[43]  S. Lipshultz,et al.  Cardiotoxicity of Cancer Chemotherapy , 2005, Paediatric drugs.

[44]  M. Siimes,et al.  Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation. , 1996, European journal of cancer.